The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease

Neurobiology of Aging
Megan M VarnumTsuneya Ikezu

Abstract

Cluster of Differentiation-200 (CD200) is an anti-inflammatory glycoprotein expressed in neurons, T cells, and B cells, and its receptor is expressed on glia. Both Alzheimer's disease patients and mouse models display age-related or amyloid-β peptide (Aβ)-induced reductions in CD200. The goal of this study was to determine if neuronal CD200 expression restores hippocampal neurogenesis and reduces Aβ in the amyloid precursor protein mouse model. Amyloid precursor protein and wild-type mice were injected at 6 months of age with an adeno-associated virus expressing CD200 into the hippocampus and sacrificed at 12 months. CD200 expression restored neural progenitor cell proliferation and differentiation in the subgranular and granular cell layers of the dentate gyrus and reduced diffuse but not thioflavin-S(+) plaques in the hippocampus. In vitro studies demonstrated that CD200-stimulated microglia increased neural differentiation of neural stem cells and enhanced axon elongation and dendrite number. CD200 also enhanced Aβ uptake by microglia. These data indicate that CD200 is capable of enhancing microglia-mediated Aβ clearance and neural differentiation and has potential as a therapeutic for Alzheimer's disease.

References

Nov 1, 1990·Journal of Neuroimmunology·H Akiyama, P L McGeer
Jan 1, 1993·Glia·P L McGeerE G McGeer
Jan 1, 1995·Clinical Anatomy : Official Journal of the American Association of Clinical Anatomists & the British Association of Clinical Anatomists·A AlzheimerF R Murtagh
Jan 23, 1999·Current Opinion in Hematology·R N Kalaria
Jun 20, 2002·Trends in Immunology·A Neil BarclayMarion H Brown
Oct 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christine T EkdahlOlle Lindvall
Nov 15, 2003·Science·Michelle L MonjeTheo D Palmer
Dec 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kunlin JinDavid A Greenberg
Apr 2, 2004·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·E MeijeringM Unser
Sep 9, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jessica Koenigsknecht-Talboo, Gary E Landreth
Sep 28, 2005·Journal of Cellular Biochemistry·Yu-Ping ChangShun-Fen Tzeng
Nov 12, 2005·Stroke; a Journal of Cerebral Circulation·Benjamin D HoehnGary K Steinberg
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Oleg ButovskyMichal Schwartz
Apr 26, 2007·The American Journal of Pathology·Tanuja ChitnisSamia J Khoury
Jun 28, 2007·Reviews in the Neurosciences·Elodie Bruel-JungermanSerge Laroche
Aug 3, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anthony LyonsMarina A Lynch
Sep 13, 2008·Nature Reviews. Immunology·Lionel B Ivashkiv
Jan 1, 2009·American Journal of Alzheimer's Disease and Other Dementias·Ludovico MinatiGiorgio Giaccone
Mar 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tomomi KiyotaTsuneya Ikezu
Sep 30, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robin MihrshahiMarion H Brown
Oct 30, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Wei DengFred H Gage
Jan 12, 2010·Journal of Alzheimer's Disease : JAD·Edith G McGeer, Patrick L McGeer
Mar 5, 2010·Fundamental & Clinical Pharmacology·Nada Choucair-JaafarJean-Pierre Gies
Apr 8, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tomomi KiyotaTsuneya Ikezu
Apr 9, 2010·Journal of Innate Immunity·Nathalie KoningJörg Hamann
Nov 5, 2010·Hippocampus·Sophie TronelDjoher Nora Abrous
Jul 23, 2011·Science·Rosa C PaolicelliCornelius T Gross
Aug 2, 2011·Nature Cell Biology·Zhenjie LuJonathan Kipnis
Nov 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tomomi KiyotaTsuneya Ikezu
May 31, 2012·Journal of Neuroinflammation·Anthony LyonsMarina A Lynch

❮ Previous
Next ❯

Citations

Nov 11, 2016·Molecular Neurobiology·Anthony LyonsMarina A Lynch
Apr 6, 2017·International Journal of Molecular Sciences·Edward C KoellhofferRodney M Ritzel
Aug 3, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jong Kil Lee, Nam-Jung Kim
Jan 10, 2018·Frontiers in Neuroscience·Kevin A ClaytonTsuneya Ikezu
Nov 16, 2019·Current Neuropharmacology·Katarzyna ChameraAgnieszka Basta-Kaim
Aug 25, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Yaguang HuQiaochu Cheng
Jun 18, 2018·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Yosra BedouiPhilippe Gasque
Nov 7, 2019·Acta Neuropathologica Communications·Christopher D WhelanOskar Hansson
Oct 16, 2018·Frontiers in Cellular Neuroscience·Zsuzsanna SzepesiTomas Deierborg
May 2, 2020·International Journal of Molecular Sciences·Roberta De GioiaStefania Corti
Mar 11, 2018·Brain, Behavior, and Immunity·Laura K FonkenSteven F Maier
Apr 8, 2021·Journal of Neuroinflammation·Neus Rabaneda-LombarteCarme Solà
Apr 17, 2021·Stem Cell Reviews and Reports·Ekaterina SemenovaNatalia Rozwadowska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.